Greg Slabodkin

#Ardena opens Good Laboratory Practices bioanalytical lab in #NewJersey. The Somerset facility adds LC-MS/MS, #immunochemistry, and sample storage capabilities to support #bioanalysis for preclinical and clinical programs. pharmamanufacturing.com/industry-news/… #CDMO #biopharma #flowcytometry

#FujifilmBiotechnologies doubles #qualitycontrol footprint at Danish commercial-scale #biomanufacturing site. The new 2,000‑square‑meter QC lab at its facility in Hillerød, #Denmark is designed to support the site's #bioreactor expansion. pharmamanufacturing.com/quality-risk/a… #Fujifilm #CDMO

#KincellBio augments #ResearchTrianglePark facility for #manufacturing #celltherapies. The #CDMO added #cleanrooms, #qualitycontrol labs, and digital systems to support commercial-scale production, validation, and release of #celltherapy products. pharmamanufacturing.com/industry-news/… #CDMOs

#VetterPharma expands clinical #manufacturing network in U.S. and Europe. The capacity additions and facility upgrades aim to support early-stage manufacturing, #asepticprocessing, and supply of #clinicaltrial materials. pharmamanufacturing.com/industry-news/… #CDMO #CDMOs #pharmamanufacturing

#GrandRiverAsepticManufacturing invests $100 million in sterile #fillfinish capacity. The #CDMO's new high-volume filling line and #GMP facility will support syringe/cartridge production with advanced isolator-based #sterileprocessing. pharmamanufacturing.com/industry-news/… #sterileinjectables

#AGCBiologics to expand #CDMO services in #Japan with new $350 million #Yokohama site. The facility, slated to be #GMP-ready in 2027, will house one of Japan's largest #SingleUseBioreactor systems for mammalian production, according to the company. pharmamanufacturing.com/sector/contrac… #AGCBio

#OxfordBiomedicaSolutions launches fast-track #viralvector #manufacturing service, which integrates upstream and downstream processes to reduce timelines to #GMP production for eligible #cellandgenetherapy programs. pharmamanufacturing.com/industry-news/… #CDMO #AAVvectors #lentiviralvectors

#Regeneron and #TelixPharmaceuticals partner on #radiopharmaceutical development. The collaboration integrates #radiopharma #manufacturing with #antibody platforms to support scalable production and development of targeted #oncology therapies. pharmamanufacturing.com/industry-news/… #biopharma

U.S. #drugsupply at risk from single-country #KeyStartingMaterial sources, finds new report from #USPharmacopeia which reveals that 48 of 100 vulnerable #medicines are potentially impacted. pharmamanufacturing.com/quality-risk/s… #pharmaceuticals #supplychain #drugshortages #China #India #KSMs

Fully autonomous #bioprocessing is reachable, but challenges remain. In this #podcast, Mel Radford, director of #lifesciences global accounts at #RockwellAutomation, discusses the key barriers to autonomy. pharmamanu.podbean.com/e/building-the… #podcasts #AI #processcontrol #automation

#Catalent and #immunecell therapy developer #Cartherics expanded a commercial license agreement to support #manufacturing and commercialization of #CARNK #celltherapies. Cartherics will use Catalent's #cGMP-compliant #inducedpluripotentstemcell line. pharmamanufacturing.com/industry-news/… #iPSC

#Avantor expands U.S. #qualitycontrol testing to support #biomanufacturing. The St. Louis site adds integrated #GMP-aligned #microbial and ICH-compliant stability testing to improve turnaround times and data visibility, according to the company. pharmamanufacturing.com/industry-news/… #biopharma

#EliLilly continues to invest in #China to strengthen local production of #GLP1 drugs. Lilly's total Chinese investment has reached nearly $6 billion, including $3 billion over the next decade to build a localized #manufacturing and supply network. pharmamanufacturing.com/quality-risk/s… #GLP1s

#BoraBiologics completed a 2,000-liter engineering scale-up and process confirmation run at its #SanDiego site, confirming operational readiness of expanded mammalian #manufacturing suites and validating systems at commercial scale. pharmamanufacturing.com/industry-news/… #biologics #biosimilar

#AltruistBiologics receives first #GMP license for 20,000L-scale #biologics facility in #China. The #Hangzhou site achieved licensure just two months after qualification and will hold a total capacity of 172,000 liters upon completion. pharmamanufacturing.com/industry-news/… #NMPA #CDMO #CDMOs

Q1 leading indicator data provides positive outlook for #biopharmaceutical #outsourcing, say #WilliamBlair analysts. #Biopharma's #funding trends, product pipeline, and pace of R&D spending indicate demand is set to improve in 2026. pharmamanufacturing.com/sector/contrac… #Lonza #CDMO #CDMOs

#Shionogi wins $119 million #BARDA contract for U.S. #antibiotic #manufacturing. The agreement supports domestic manufacturing, procurement, and expanded development of #Fetroja for #biothreat-related infections. pharmamanufacturing.com/industry-news/… #antibiotics #pathogens #healthsecurity

#Contractmanufacturing deals for drugs marketed in U.S. shifting to #Europe, according to #GlobalData. #Biopharma companies are increasingly choosing to outsource #manufacturing for the U.S. market to European facilities. pharmamanufacturing.com/sector/contrac… #CDMO #CDMOs #EU #tariffs #Trump

#ScinaiImmunotherapeutics separates contract development and manufacturing organization business from R&D operations, establishing a dedicated #CDMO subsidiary while streamlining its #therapeutics development business. pharmamanufacturing.com/industry-news/… #biologics #smallmolecule #Israel

#Recipharm reduces Scope 1 and 2 #emissions, achieves #renewablepower goal. The #CDMO cited lower #greenhousegas emissions, reduced water use and continued investment in #sustainable #manufacturing. pharmamanufacturing.com/industry-news/… #sustainability #greenhousegases #climatechange #CDMOs